Astex - PDFSEARCH.IO - Document Search Engine

Astex
Results: 79

#	Item
61	Astex Pharmaceuticals Announces Subcutaneous SGI-110 Interim Phase 1/2 MDS and AML Data Presentation at AACR DUBLIN, Calif., April 3, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical c Add to Reading List Source URL: astx.com Language: English Acute myeloid leukemia Myeloid leukemia Myelodysplastic syndrome Astex Decitabine Oncology Medicine Acute leukemia
62	August 20, 2012 Astex President Awarded Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery DUBLIN, Calif., Aug. 20, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharm Add to Reading List Source URL: astx.com Language: English Astex Drug discovery Pharmaceutical sciences Medicinal chemistry Pharmacology
63	October 14, 2013 Astex Pharmaceuticals to Present at AACR-NCI-EORTC DUBLIN, Calif., Oct. 14, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc., a pharmaceutical company dedicated to the discovery and development of n Add to Reading List Source URL: astx.com Language: English
64	Astex Pharmaceuticals to Present at AACR Annual Meeting DUBLIN, Calif., March 29, [removed]Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), a pharmaceutical company dedicated to the discovery and development of novel small mole Add to Reading List Source URL: astx.com Language: English Astex Protein kinase inhibitors Drug discovery Aurora inhibitor Pharmaceutical sciences Pharmacology Biology
65	November 20, 2012 Astex Pharmaceuticals Announces Oral Presentation of SGI-110 Results From Phase 1/2 MDS and AML Study at ASH DUBLIN, Calif., Nov. 20, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), Add to Reading List Source URL: astx.com Language: English Acute myeloid leukemia Myeloid leukemia Myelodysplastic syndrome Clinical research Astex Leukemia Clinical trial Medicine Health Acute leukemia
66	Astex To Present Data From Its FGFR Inhibitor Programme at the American Association for Cancer Research (AACR) 102nd Annual Meeting 2011 Cambridge, UK, 29th March[removed]Astex Therapeutics, the UK-based biotechnology comp Add to Reading List Source URL: astx.com Language: English Pharmacology Clinical research Medicinal chemistry Astex Fibroblast growth factor receptor 1 Fibroblast growth factor receptor Tyrosine kinase Fibroblast growth factor Protein kinase Pharmaceutical sciences Biology Tyrosine kinase receptors
67	Astex Earns Milestone Payment on Initiation of Phase 3 Study Add to Reading List Source URL: astx.com Language: English Cambridge Science Park Novartis Drug discovery Pharmaceutical sciences Pharmacology Astex
68	ACTIVITY OF THE HSP90 INHIBITOR, AT13387, IN ALK-DRIVEN TUMOR MODELS. Nicola Wallis, Tomoko Smyth, Joanne Munck, Ana Rodriguez-Lopez, Victoria Lock, Rachel McMenamin, Neil Thompson & John Lyons Astex Pharmaceuticals, 436 Add to Reading List Source URL: astx.com Language: English - Date: 2012-12-17 16:09:22 Organofluorides Oncology Crizotinib Piperidines Pyrazoles Pyridines ALK inhibitor Anaplastic lymphoma kinase Non-small-cell lung carcinoma Lung cancer Medicine Chemistry
69	Sustaining Innovation Postdoctoral Fellowships Astex Pharmaceuticals, a world leader in innovative drug discovery, has launched a new Postdoctoral training programme that aims to maintain and Add to Reading List Source URL: astx.com Language: English - Date: 2014-12-11 05:21:43 Drug discovery Pharmaceutical sciences Pharmacology Astex
70	Scale up and development of a process for a low volume subcutaneous formulation of SGI‐110, a potent hypomethylating agent Sanjeev Redkar Astex Pharmaceuticals, Inc., Dublin, CA Add to Reading List Source URL: astx.com Language: English - Date: 2012-12-13 18:06:00 Chemistry Triazines Decitabine DNA methyltransferase DNA methylation Myelodysplastic syndrome Deoxyribose Deoxyguanosine Hypomethylating agent Nucleosides Medicine Biology

UPDATE